February 25, 2019—Canada should not be classified as a “free rider” in drug pricing according to a new report from the C.D. Howe Institute. In “High Drug Prices, Big R&D Spenders and “Free Riders”: Canada in the Topsy Turvy World of Pharmaceuticals,” authors Åke…
Read moreBill C-69 threatens to further depress investment in the natural resources sector and delay projects by unnecessarily exposing them to political risk, says a new report from the C.D. Howe Institute.
The planned investment value of major resource sector projects plunged $100 billion…
Read moreFebruary 14, 2019 - Misuse of laboratory testing in Canada is costly and potentially harmful, according to a new report from the C.D. Howe Institute. In “What the Doctor Ordered: Improving the Use and Value of Laboratory Testing” authors Christopher Naugler and Rosalie Wyonch argue that reducing…
Read moreFebruary 7 – Ottawa should spur growth through better tax competitiveness and get back into the black by curbing overspending, says the C.D. Howe Institute’s annual Shadow Federal Budget.
In “Less Debt, More Growth: A Shadow Federal Budget for 2019”, authors William B.P. Robson and…
Read more